1. Scheibe, Kristina, Kersten, Christina, Schmied, Anabel, Neurath, Markus F, Neufert, Clemens. 2018. Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation. In Gastroenterology, 156, 1082-1097.e11. doi:10.1053/j.gastro.2018.11.029. https://pubmed.ncbi.nlm.nih.gov/30452921/
2. Ha, Xuemei, Li, Yue, Gao, Zihui, Sun, Lihua, Gao, Wenzhi. 2024. IL1RL2 is related to the expression and prognosis of bladder cancer. In Molecular and clinical oncology, 21, 75. doi:10.3892/mco.2024.2773. https://pubmed.ncbi.nlm.nih.gov/39170626/
3. Tongmuang, Nopprarat, Cai, Kathy Q, An, Jiahui, Novy, Mariah, Jensen, Liselotte E. 2024. Floxed Il1rl2 Locus with mCherry Reporter Element Reveals Distinct Expression Patterns of the IL-36 Receptor in Barrier Tissues. In Cells, 13, . doi:10.3390/cells13090787. https://pubmed.ncbi.nlm.nih.gov/38727323/
4. Liang, Zhongqing, Sun, Ruolan, Tu, Pengcheng, Gu, Junfei, Tang, Decai. 2022. Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma. In Frontiers in immunology, 13, 944286. doi:10.3389/fimmu.2022.944286. https://pubmed.ncbi.nlm.nih.gov/36591255/
5. Hao, Mengdi, Li, Huimin, Yi, Meng, Liang, Xiaoqing, Ding, Lei. 2023. Development of an immune-related gene prognostic risk model and identification of an immune infiltration signature in the tumor microenvironment of colon cancer. In BMC gastroenterology, 23, 58. doi:10.1186/s12876-023-02679-6. https://pubmed.ncbi.nlm.nih.gov/36890467/
6. Husain, Hadiya, Waseem, Mohammad, Ahmad, Riaz. 2021. Proteomic and molecular evidences of Il1rl2, Ric8a, Krt18 and Hsp90b1 modulation during experimental hepatic fibrosis and pomegranate supplementation. In International journal of biological macromolecules, 185, 696-707. doi:10.1016/j.ijbiomac.2021.06.091. https://pubmed.ncbi.nlm.nih.gov/34174316/
7. van Eijck, Casper W F, Sabroso-Lasa, Sergio, Strijk, Gaby J, Malats, Núria, van Eijck, Casper H J. 2024. A liquid biomarker signature of inflammatory proteins accurately predicts early pancreatic cancer progression during FOLFIRINOX chemotherapy. In Neoplasia (New York, N.Y.), 49, 100975. doi:10.1016/j.neo.2024.100975. https://pubmed.ncbi.nlm.nih.gov/38335839/
智鼠故事 
